Abstract
Background
Lymphedema is a frequent complication after breast cancer treatment. Reduction of lymphedema volume is obtained during an intensive phase with daily physiotherapy. Response to treatment remains unknown prior treatment. We purposed to analyze predictors of response of lymphedema treatment throughout the first course of physiotherapy.
Design
Patients with secondary arm lymphedema were recruited in a single lymphology unit between 2001 and 2004. For each patient, the following data were recorded: characteristics of breast cancer treatment, patient characteristics, body mass index and lymphedema volume prior and at the end of treatment.
Results
Three hundred and fifty-seven women (mean age: 53±11 years) were included. Initial excess volume of lymphedema was correlated to body mass index and duration of lymphedema. Mean duration of intensive decongestive therapy was 11.8±3.3 days. Mean excess volume of lymphedema was 1067±622 ml prior treatment and 663±366 ml after treatment (p<0.001), percentage of excess volume of lymphedema was 59±34% and 36±19%, respectively. Absolute volume reduction was 404±33 ml (p<0.001). Body mass index and duration of lymphedema before treatment were the two predictors of absolute reduction of lymphedema volume. Higher was the body mass index or the duration of lymphedema, more important was the absolute reduction of lymphedema volume. Mean relative percentage of volume reduction was 36±14% whatever mass index or the duration of lymphedema was.
Conclusion
Duration of lymphedema from cancer treatment and body mass index were the only two predictors of absolute reduction of lymphedema volume after intensive decongestive physiotherapy. For all patients this latter treatment is highly effective in management of secondary upper limb lymphedema after breast cancer.
Similar content being viewed by others
References
Meric F, Buchholz TA, Mirza NQ, Vlastos G, Ames FC, Ross MI, Pollock RE, Singletary SE, Feig BW, Kuerer HM, Newman LA, Perkins GH, Strom EA, McNeese MD, Hortobagyi GN, Hunt KK, 2002 Long-term complications associated with breast-conservation surgery and radiotherapy Ann Surg Oncol 9: 543–549
Ozaslan C, Kuru B, 2004 Lymphedema after treatment of breast cancer Am J Surg 187: 69–72
Clark B, Sitzia J, Harlow W, 2005 Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study Q J Med 98: 343–348
Petrek JA, Senie RT, Peters M, Rosen PP, 2001 Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis Cancer 92: 1368–1377
Földi E, Földi M, Clodius L, 1989 The lymphedema chaos: a lancet Ann Plast Surg 22: 505–515
Ko DS, Lerner R, Klose G, Cosimi AB, 1998 Effective treatment of lymphedema of the extremities Arch Surg 133: 452–458
Szuba A, Cooke JP, Yousuf S, Rockson SG, 2000 Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema Am J Med 109:296–300
Johansson K, Albertsson M, Ingvar C, Ekdahl C, 1999 Effects of compression bandaging with or without manual lymph drainage treatment in patients with postoperative arm lymphedema Lymphology 32: 103–110
Boris M, Weindorf S, Lasinski B, Boris G, 1994 Lymphedema reduction by non-invasive complex lymphedema therapy Oncology 8: 95–106
Casley-Smith JR, Casley-Smith JR, 1992 Modern treatment of lymphoedema I Complex physical therapy: the first 200 australian limbs Australas J Dermatol 33: 61–68
Lennihan R Jr, Mackereth M, 1973 Calculating volume changes in a swollen extremity from surface measurements Am J Surg 126:649–652
Sitzia J, 1995 Volume measurement in lymphoedema treatment: examination of formulae Eur J Cancer Care 4: 11–16
Megens AM, Harris SR, Kim-Sing C, McKenzie DC, 2001 Measurement of upper extremity volume in women after axillary dissection for breast cancer Arch Phys Med Rehabil 82: 1639–1644
Galland C, Auvert JF, Flahault A, Vayssairat M, 2002 Why and how post-mastectomy edema should be quantified in patients with breast cancer Breast Cancer Res Treat 75: 87–89
Harris SR, Hugi MR, Olivotto IA, Levine M, 2001 Steering committee for clinical practice guidelines for the care and treatment of breast cancer: clinical practice guidelines for the care and treatment of breast cancer: 11 Lymphedema. CMAJ 164:191–199
International Society of Lymphology 2003 The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology Lymphology 36: 84–91
Szuba A, Rockson SG, 1997 Lymphedema: anatomy, physiology and pathogenesis. Vasc Med 2: 321–326
Dimakakos PB, Stefanopoulos Th, Antoniades P, Antoniou A, Gouliamos A, Rizos D, 1997 MRI and ultrasonographic findings in the investigation of lymphedema and lipedema Int Surg 82:411–416
Marotel M, Cluzan R, Ghabboun S, Pascot , Alliot F, Lasry JL, 1998 Transaxial computer tomography of lower extremity lymphedema Lymphology 31: 180–185
Bioelectrical impedance analysis in body composition measurement 1996 National Institutes of Health Technology Assessment Conference Statement: Am J Clin Nutr 64(3 Suppl):524S-532S
Segerström K, Bjerle P, Graffman S, Nystrom A, 1992 Factors that influence the incidence of brachial oedema after treatment of breast cancer Scand J Plast Reconstr Hand Surg 26: 223–227
Werner RS, McCormick B, Petrek J, Cox L, Cirrincione C, Gray JR, Yahalom J, 1991 Arm edema in conservatively managed breast cancer: obesity is a major predictive factor Radiology 180: 177–184
Johansson K, Ohlsson K, Ingvar C, Albertsson M, Ekdahl C, 2002 Factors associated with the development of arm lymphedema following breast cancer treatment: a match pair case-control study Lymphology 35: 59–71
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vignes, S., Porcher, R., Champagne, A. et al. Predictive Factors of Response to Intensive Decongestive Physiotherapy in Upper Limb Lymphedema After Breast Cancer Treatment: a Cohort Study. Breast Cancer Res Treat 98, 1–6 (2006). https://doi.org/10.1007/s10549-005-9021-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-005-9021-y